Vandré C Figueiredo1,2,3, Randall F D'Souza1, Douglas W Van Pelt2,3, Marcus M Lawrence4, Nina Zeng1, James F Markworth1, Sally D Poppitt5, Benjamin F Miller4, Cameron J Mitchell1,6, John J McCarthy3,7, Esther E Dupont-Versteegden2,3, David Cameron-Smith1,8,9. 1. Liggins Institute, The University of Auckland, Auckland, New Zealand. 2. Department of Physical Therapy, College of Health Sciences, University of Kentucky, KY, USA. 3. Center of Muscle Biology, University of Kentucky, KY, USA. 4. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, OK, USA. 5. School of Biological Sciences, The University of Auckland, Auckland, New Zealand. 6. School of Kinesiology, University of British Columbia, Vancouver, Canada. 7. College of Medicine, University of Kentucky, KY, USA. 8. Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 9. Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Singapore.
Abstract
BACKGROUND: Translational capacity (i.e. ribosomal mass) is a key determinant of protein synthesis and has been associated with skeletal muscle hypertrophy. The role of translational capacity in muscle atrophy and regrowth from disuse is largely unknown. Therefore, we investigated the effect of muscle disuse and reloading on translational capacity in middle-aged men (Study 1) and in rats (Study 2). METHODS: In Study 1, 28 male participants (age 50.03 ± 3.54 years) underwent 2 weeks of knee immobilization followed by 2 weeks of ambulatory recovery and a further 2 weeks of resistance training. Muscle biopsies were obtained for measurement of total RNA and pre-ribosomal (r)RNA expression, and vastus lateralis cross-sectional area (CSA) was determined via peripheral quantitative computed tomography. In Study 2, male rats underwent hindlimb suspension (HS) for either 24 h (HS 24 h, n = 4) or 7 days (HS 7d, n = 5), HS for 7 days followed by 7 days of reloading (Rel, n = 5) or remained as ambulatory weight bearing (WB, n = 5) controls. Rats received deuterium oxide throughout the study to determine RNA synthesis and degradation, and mTORC1 signalling pathway was assessed. RESULTS: Two weeks of immobilization reduced total RNA concentration (20%) and CSA (4%) in men (both P ≤ 0.05). Ambulatory recovery restored total RNA concentration to baseline levels and partially restored muscle CSA. Total RNA concentration and 47S pre-rRNA expression increased above basal levels after resistance training (P ≤ 0.05). In rats, RNA synthesis was 30% lower while degradation was ~400% higher in HS 7d in soleus and plantaris muscles compared with WB (P ≤ 0.05). mTORC1 signalling was lower in HS compared with WB as was 47S pre-rRNA (P ≤ 0.05). With reloading, the aforementioned parameters were restored to WB levels while RNA degradation was suppressed (P ≤ 0.05). CONCLUSIONS: Changes in RNA concentration following muscle disuse and reloading were associated with changes in ribosome biogenesis and degradation, indicating that both processes are important determinants of translational capacity. The pre-clinical data help explain the reduced translational capacity after muscle immobilization in humans and demonstrate that ribosome biogenesis and degradation might be valuable therapeutic targets to maintain muscle mass during disuse.
BACKGROUND: Translational capacity (i.e. ribosomal mass) is a key determinant of protein synthesis and has been associated with skeletal muscle hypertrophy. The role of translational capacity in muscle atrophy and regrowth from disuse is largely unknown. Therefore, we investigated the effect of muscle disuse and reloading on translational capacity in middle-aged men (Study 1) and in rats (Study 2). METHODS: In Study 1, 28 male participants (age 50.03 ± 3.54 years) underwent 2 weeks of knee immobilization followed by 2 weeks of ambulatory recovery and a further 2 weeks of resistance training. Muscle biopsies were obtained for measurement of total RNA and pre-ribosomal (r)RNA expression, and vastus lateralis cross-sectional area (CSA) was determined via peripheral quantitative computed tomography. In Study 2, male rats underwent hindlimb suspension (HS) for either 24 h (HS 24 h, n = 4) or 7 days (HS 7d, n = 5), HS for 7 days followed by 7 days of reloading (Rel, n = 5) or remained as ambulatory weight bearing (WB, n = 5) controls. Rats received deuterium oxide throughout the study to determine RNA synthesis and degradation, and mTORC1 signalling pathway was assessed. RESULTS: Two weeks of immobilization reduced total RNA concentration (20%) and CSA (4%) in men (both P ≤ 0.05). Ambulatory recovery restored total RNA concentration to baseline levels and partially restored muscle CSA. Total RNA concentration and 47S pre-rRNA expression increased above basal levels after resistance training (P ≤ 0.05). In rats, RNA synthesis was 30% lower while degradation was ~400% higher in HS 7d in soleus and plantaris muscles compared with WB (P ≤ 0.05). mTORC1 signalling was lower in HS compared with WB as was 47S pre-rRNA (P ≤ 0.05). With reloading, the aforementioned parameters were restored to WB levels while RNA degradation was suppressed (P ≤ 0.05). CONCLUSIONS: Changes in RNA concentration following muscle disuse and reloading were associated with changes in ribosome biogenesis and degradation, indicating that both processes are important determinants of translational capacity. The pre-clinical data help explain the reduced translational capacity after muscle immobilization in humans and demonstrate that ribosome biogenesis and degradation might be valuable therapeutic targets to maintain muscle mass during disuse.
Authors: Imre W K Kouw; Bart B L Groen; Joey S J Smeets; Irene Fleur Kramer; Janneau M X van Kranenburg; Rachél Nilwik; Jan A P Geurts; René H M Ten Broeke; Martijn Poeze; Luc J C van Loon; Lex B Verdijk Journal: J Am Med Dir Assoc Date: 2018-08-11 Impact factor: 4.669
Authors: Rainer W J Kaiser; Michael Ignarski; Eric L Van Nostrand; Christian K Frese; Manaswita Jain; Sadrija Cukoski; Heide Heinen; Melanie Schaechter; Lisa Seufert; Konstantin Bunte; Peter Frommolt; Patrick Keller; Mark Helm; Katrin Bohl; Martin Höhne; Bernhard Schermer; Thomas Benzing; Katja Höpker; Christoph Dieterich; Gene W Yeo; Roman-Ulrich Müller; Francesca Fabretti Journal: Sci Rep Date: 2019-07-30 Impact factor: 4.379
Authors: Benjamin F Miller; Leslie M Baehr; Robert V Musci; Justin J Reid; Frederick F Peelor; Karyn L Hamilton; Sue C Bodine Journal: J Cachexia Sarcopenia Muscle Date: 2019-07-16 Impact factor: 12.910
Authors: Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker Journal: J Cachexia Sarcopenia Muscle Date: 2019-10 Impact factor: 12.910
Authors: Vandré C Figueiredo; Randall F D'Souza; Douglas W Van Pelt; Marcus M Lawrence; Nina Zeng; James F Markworth; Sally D Poppitt; Benjamin F Miller; Cameron J Mitchell; John J McCarthy; Esther E Dupont-Versteegden; David Cameron-Smith Journal: J Cachexia Sarcopenia Muscle Date: 2020-11-24 Impact factor: 12.910
Authors: Kamil A Kobak; Marcus M Lawrence; Gavin Pharaoh; Agnieszka K Borowik; Frederick F Peelor; Patrick D Shipman; Timothy M Griffin; Holly Van Remmen; Benjamin F Miller Journal: J Cachexia Sarcopenia Muscle Date: 2021-08-21 Impact factor: 12.910
Authors: Jamie-Lee M Thompson; Daniel W D West; Thomas M Doering; Boris P Budiono; Sarah J Lessard; Lauren G Koch; Steven L Britton; Nuala M Byrne; Matthew A Brown; Kevin J Ashton; Vernon G Coffey Journal: PLoS One Date: 2022-01-13 Impact factor: 3.240
Authors: Nima Gharahdaghi; Supreeth Rudrappa; Matthew S Brook; Wesam Farrash; Iskandar Idris; Muhammad Hariz Abdul Aziz; Fawzi Kadi; Konstantinos Papaioannou; Bethan E Phillips; Tanvir Sian; Philip J Herrod; Daniel J Wilkinson; Nathaniel J Szewczyk; Kenneth Smith; Philip J Atherton Journal: J Cachexia Sarcopenia Muscle Date: 2022-03-01 Impact factor: 12.910